
AI identifies drug combinations to fight COVID-19
Data scientists have used deep learning to identify the right synergistic drug combinations for the rapidly spreading SARS-CoV-2.
Data scientists have used deep learning to identify the right synergistic drug combinations for the rapidly spreading SARS-CoV-2.
Studying these organoids could help researchers develop and test new treatments for pancreatic cancer.
The MasSpec Pen has shown to accurately differentiate healthy and cancerous tissue from banked pancreas samples during surgery.
The MasSpec Pen has shown to accurately identify tissues and surgical margins directly in patients and differentiate healthy and cancerous tissue from banked pancreas samples.
An organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer.
Researchers have experimentally demonstrated a novel cancer diagnosis technique based on the scattering of circularly polarized light.
EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds.
Scientists have now developed guidelines that should enable the safe development of nanoparticles for medical use.
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.